To Be Discontinued Tablet Anti-Infective

Doxycycline Hyclate Tablet · 6 active FDA presentation rows for this drug

Brand: DOXYCYCLINE HYCLATE

FDA lists Doxycycline Hyclate Tablet as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).

No availability text on this FDA row.

Doxycycline Hyclate Tablet: To Be Discontinued

FDA availability text is not recorded on this row. 6 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Doxycycline Hyclate Tablet
Manufacturer
Teva Pharmaceuticals USA, Inc.
Dosage Form
Tablet
Presentation
Doxycycline Hyclate, Tablet, 100 mg (NDC 0591-5553-50)
Package NDC
0591-5553-50

Status & Timeline

Status
To Be Discontinued
First Reported
Jun 13, 2025
Last Updated
Jun 13, 2025
Therapeutic Category
Anti-Infective

Row fields from the FDA Drug Shortages database via openFDA.

Full Drug Profile

doxycycline

Side effects, interactions, warnings & more

View Profile
Compare doxycycline with alternatives →

Nearby, Other Doxycycline Shortage Records

Doxycycline Hyclate Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Doxycycline Hyclate Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Doxycycline Hyclate Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Doxycycline Hyclate Tablet

Mylan Pharmaceuticals Inc., a Viatris Company

Tablet

To Be Discontinued

Doxycycline Hyclate Tablet

Mylan Pharmaceuticals Inc., a Viatris Company

Tablet

To Be Discontinued
← All Drug Shortages